知临集团上涨123.62%，报2.84美元/股，总市值2028.83万美元

Core Insights - The stock of APM (知临集团) opened with a significant increase of 123.62%, reaching $2.84 per share, with a trading volume of $253 million and a total market capitalization of $20.2883 million [1] Financial Performance - As of December 31, 2023, APM reported total revenue of $431,400, representing a year-over-year decrease of 66.71% [1] - The company recorded a net loss attributable to shareholders of $2.8246 million, which is an increase of 71.18% compared to the previous year [1] Company Overview - APM is a biopharmaceutical company focused on the research and commercialization of innovative medical and diagnostic technologies to address unmet medical needs [1] - The company's drug development projects target orphan diseases, infectious diseases, and metabolic disorders, with some projects aimed to enter clinical trials by 2020 [1] - APM also operates a women's health product line, with its Dioscorea Opposita bioactive nutritional tablets currently in commercialization [1]